Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Magni

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Blood|May 3, 2002
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuliMassimo Di Nicola, Carmelo Carlo-Stella, Michele Magni, et al.
Veterinary Record Open|November 23, 2020
Reproductive parameters in some captive-bred cockatoo species (genus <i>Cacatua</i> and <i>Eolophus</i>)Stefano Paolo Marelli, Ahmad Abdel Sayed, Michele Magni, et al.
Cancer Research|November 5, 2002
Defibrotide in combination with granulocyte colony-stimulating factor significantly enhances the mobilization of primitive and committed peripheral blood progenitor cells in miceCarmelo Carlo-Stella, Massimo Di Nicola, Michele Magni, et al.
Haematologica|December 6, 2006
Long-term results of a risk-adapted approach to melphalan conditioning in autologous peripheral blood stem cell transplantation for primary (AL) amyloidosisVittorio Perfetti, Salvatore Siena, Giovanni Palladini, et al.
Leukemia & Lymphoma|June 10, 2010
Long-term results of high-dose chemotherapy with autologous bone marrow or peripheral stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin lymphoma: a single institution experienceSimonetta Viviani, Massimo Di Nicola, Valeria Bonfante, et al.
British Journal of Haematology|September 9, 2004
High response rate and manageable toxicity with an intensive, short-term chemotherapy programme for Burkitt's lymphoma in adultsMassimo Di Nicola, Carmelo Carlo-Stella, Jacopo Mariotti, et al.
Human Gene Therapy|November 17, 2006
Antitumor activity of human CD34+ cells expressing membrane-bound tumor necrosis factor-related apoptosis-inducing ligandCarmelo Carlo-Stella, Cristiana Lavazza, Massimo Di Nicola, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2008
High-dose yttrium-90-ibritumomab tiuxetan with tandem stem-cell reinfusion: an outpatient preparative regimen for autologous hematopoietic cell transplantationLiliana Devizzi, Anna Guidetti, Corrado Tarella, et al.
Haematologica|December 23, 2003
Dendritic cell viability is decreased after phagocytosis of apoptotic tumor cells induced by staurosporine or vaccinia virus infectionMassimo Di Nicola, Sara Napoli, Andrea Anichini, et al.
Experimental Hematology|January 17, 2004
Mobilization of primitive and committed hematopoietic progenitors in nonhuman primates treated with defibrotide and recombinant human granulocyte colony-stimulating factorCarmelo Carlo-Stella, Massimo Di Nicola, Paolo Longoni, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Blood|May 3, 2002
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuliMassimo Di Nicola, Carmelo Carlo-Stella, Michele Magni, et al.
Veterinary Record Open|November 23, 2020
Reproductive parameters in some captive-bred cockatoo species (genus <i>Cacatua</i> and <i>Eolophus</i>)Stefano Paolo Marelli, Ahmad Abdel Sayed, Michele Magni, et al.
Cancer Research|November 5, 2002
Defibrotide in combination with granulocyte colony-stimulating factor significantly enhances the mobilization of primitive and committed peripheral blood progenitor cells in miceCarmelo Carlo-Stella, Massimo Di Nicola, Michele Magni, et al.
Haematologica|December 6, 2006
Long-term results of a risk-adapted approach to melphalan conditioning in autologous peripheral blood stem cell transplantation for primary (AL) amyloidosisVittorio Perfetti, Salvatore Siena, Giovanni Palladini, et al.
Leukemia & Lymphoma|June 10, 2010
Long-term results of high-dose chemotherapy with autologous bone marrow or peripheral stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin lymphoma: a single institution experienceSimonetta Viviani, Massimo Di Nicola, Valeria Bonfante, et al.
British Journal of Haematology|September 9, 2004
High response rate and manageable toxicity with an intensive, short-term chemotherapy programme for Burkitt's lymphoma in adultsMassimo Di Nicola, Carmelo Carlo-Stella, Jacopo Mariotti, et al.
Human Gene Therapy|November 17, 2006
Antitumor activity of human CD34+ cells expressing membrane-bound tumor necrosis factor-related apoptosis-inducing ligandCarmelo Carlo-Stella, Cristiana Lavazza, Massimo Di Nicola, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2008
High-dose yttrium-90-ibritumomab tiuxetan with tandem stem-cell reinfusion: an outpatient preparative regimen for autologous hematopoietic cell transplantationLiliana Devizzi, Anna Guidetti, Corrado Tarella, et al.
Haematologica|December 23, 2003
Dendritic cell viability is decreased after phagocytosis of apoptotic tumor cells induced by staurosporine or vaccinia virus infectionMassimo Di Nicola, Sara Napoli, Andrea Anichini, et al.
Experimental Hematology|January 17, 2004
Mobilization of primitive and committed hematopoietic progenitors in nonhuman primates treated with defibrotide and recombinant human granulocyte colony-stimulating factorCarmelo Carlo-Stella, Massimo Di Nicola, Paolo Longoni, et al.
Pageof 5